- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Generic Drugs
Mylan Inc/PA
+ Add to WatchlistMYL:US
31.7500 USD 0.2000 0.63%
Share
As of 20:10:00 ET on 05/23/2013.
More on MYL
News for Mylan Inc/PA (MYL)
-
COMPANY NEWS
-
PRESS RELEASES
-
INDUSTRY NEWS
- Kasowitz Benson, Eversheds, Latham: Business of Law
- Actavis Lowers Tax Rate to 17% After Warner Chilcott Deal
- Sanofi, Roll Global, Heineken, WWE: Intellectual Property
- Actavis to Buy Warner Chilcott in Women’s Health Effort
- Lupin Plunges Most in 2 Years as Credit Suisse Downgrades Stock
- Activist Investing: Money Moves (05/14)
- Actavis Gaining More From Purchase Than Sale: Real M&A
- Return to Activism: Street Smart (05/14)
- Bonanza Creek’s 19% Surge Canceled as Other Swings Stands
- Actavis Said to Have Rejected $15 Billion Offer From Mylan
- Actavis Said to Have Spurned $15 Billion Offer
- Actavis Said to Have Spurned $15 Billion Offer
- S&P 500 Changes in Short Interest as Percentage of Float
- Actavis Seen Selling for Higher Valuation: Real M&A
- Raptor Drug Wins U.S. Approval to Treat Rare Disease
- The Zacks Analyst Blog Highlights: Zumiez, Mylan, AbbVie, Santarus and Jazz Pharmaceuticals Published 19 hours ago
- "Modern Family" Star Julie Bowen Calls on Communities to Raise Their Hand for Anaphylaxis Awareness in Nationwide Competition Published May 21, 2013
- Federal Appellate Court Rules in Favor of Mylan in Patent Infringement Litigation Relating to Sunovion's Brovana® Product Published May 21, 2013
- PCA SKIN Announces New Executive Leadership as Company Continues to See Fast-Paced Growth Published May 20, 2013
- Mylan Launches Generic Tricor® Tablets Published May 17, 2013
- Mylan Launches Generic Zomig® Tablets Published May 15, 2013
- Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Published May 10, 2013
- Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62 Published May 02, 2013
- Deborah Autor, FDA's Deputy Commissioner for Global Regulatory Operations and Policy, to Join Mylan Published Apr 30, 2013
- Mylan Specialty L.P. Announces 25th Anniversary Celebration of EpiPen® (epinephrine) Auto-Injector Published Apr 25, 2013
- Forest Laboratories, Inc. Reports Fiscal Year Fourth Quarter 2013 Earnings Per Share of $0.17 Including $0.08 Per Share of Published Apr 23, 2013
- Jyothy Woos Urban Women to Raise Deodorant Sales Sixfold Updated 4 hours ago
- India Said to Seek Review of U.S. Court Ruling Papers on Ranbaxy
- Nintendo, P&G, Interflora: Intellectual Property
- Kasowitz Benson, Eversheds, Latham: Business of Law
- Actavis Lowers Tax Rate to 17% After Warner Chilcott Deal
- Sanofi, Roll Global, Heineken, WWE: Intellectual Property
- Teva Bets on Reformulating Old Drugs as Investors Say ‘Show Me’
- The Top Ten Stocks for May 20
- Actavis to Buy Warner Chilcott in Women’s Health Effort
- Lupin Plunges Most in 2 Years as Credit Suisse Downgrades Stock
- S&P 500 Stocks Biggest Weekly Changes in Target Price
- Billionaire Frost Props Up Prolor Bid With Stock Buys
- Sebelius Limited Fundraising For Health Law to Two Calls
- Teva U.S. Jump Widens Holiday Discount: Israel Overnight
- Actavis Gaining More From Purchase Than Sale: Real M&A
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Advertisement
Rate this Page